a new daily disposable contact lens with aspheric optics

Volume 1 | Edition 1 | 2008
WELCOME TO THE INAUGURAL EDITION OF EYEMATTERS - VISION CENTER EDITION.
This newsletter gives you the opportunity to get quick facts on topics relevant to your
day-to-day work. Keeping up to date on product facts and knowing what’s new in the
industry is a key factor in good patient management. The format of the EyeMatters
newsletter is also structured with our busy schedules in mind. You will get the bottom
line on important topics. You’re also invited to share your ideas for future topics.
I hope you find the EyeMatters newsletter to be a helpful tool.
A NEW DAILY DISPOSABLE
CONTACT LENS WITH
ASPHERIC OPTICS
SofLens® daily disposable, the latest contact lens
from Bausch & Lomb, has aspheric optics that
consistently reduce spherical aberration.5 It also
has a special packaging solution to support all
– Bill Baldwin OD, 2007 Wal-Mart Optometrist of the Year, Griffin, Georgia
day comfort. These features make it a great
upgrade for your current daily disposable
patients.
IMPROVING ASTIGMATIC PATIENTS’ VISION
Patients rely on you to deliver the best vision possible. In a recent Gallup survey, prospective
lens wearers ranked the opportunity for better vision equal to comfort as the main reason
they were interested in wearing contact lenses.1
Many of today’s toric lenses feature advanced material properties, surface technologies, and
innovations in geometric design. At the end of the day, however, astigmatic patients simply
want incredible vision. To deliver this core benefit, it’s important to follow these 3 simple rules:
#1 – Fit astigmatic patients in a toric lens.
Too many astigmatic patients still wear
spherical lenses, compromising visual acuity.
A clinical study showed that 88.7% of
patients achieved 20/20 vision or better after
one month of wearing Bausch & Lomb
PureVision® Toric lenses compared to 34.7%
achieving 20/20 vision or better in their
previous spherical correction. Crisp, clear
vision is what patients want.2
#2 – Fit them with highly stable,
well-centered lenses. Many toric lens
designs have been refined to provide
extremely stable, clear vision. A welldesigned toric lens will also achieve full
centration, providing better optical quality.
For instance, the Lo-Torque® design of the
PureVision Toric lens provides exceptional
rotational stability, and is consistently
preferred across a variety of stability metrics
by eye care practitioners when compared to
alternatives like the dual thin zone design.3
Here are the facts about what the lens offers:
• Crisp, clear vision with aspheric optics,
designed to reduce spherical aberration across
all powers and to deliver high-quality vision –
especially in low-light conditions.
I]Zine^XVaZnZ]Vh
%#&*b^Xgdchd[
he]Zg^XVaVWZggVi^dc
100%
88.7%
80%
H^bjaViZYgZi^cVa^bV\Zl^i]+bbeje^a
60%
L^i]Hd[aZchYV^an
Y^hedhVWaZViÄ&#%%9
he]Zg^XVaVWZggVi^dc
^hgZYjXZYid
%#%)b^Xgdch*
40%
20%
34.7%
H^bjaViZYgZi^cVa^bV\Zl^i]+bbeje^a
0%
% of patients
• Outstanding all-day comfort - Reduced mass
Prior spheric wearer
PureVision Toric wearer
design and non-ionic hilafilcon B lens material
reduce lens-lid interaction and inhibit deposits.
Unique lens storage solution envelops lenses in
a cushion of moisture.
100%
80%
88%
77%
60%
8ZciZg
I]^X`cZhh
HA99%#%.bb
HAD9%#&,bb
40%
20%
12%
0%
Stable Vision
PureVision Toric
Rotational
Stability
ACUVUE Advance for Astigmatism
#3 – Leverage spherical aberration
technology. Anterior aspheric optics
complement lens stability by focusing on higher order aberration correction, reducing glare
and halos, particularly in low light conditions. In a separate comparative study, patients stated
PureVision Toric lenses with aspheric design showed significant visual improvements in vision
quality over the leading hydrogel toric lens.4
These results firmly support the value of transitioning
astigmatic patients to a lens with aspheric lens technology.
EdhiZg^dg
Dei^XOdcZ
HA99&&#-bb
HAD9&'#)bb
23%
LLearn
earn M
More
ore
@:N/
HA992Hd[AZchYV^anY^hedhVWaZ HAD92Hd[AZchdcZYVn
• Easy
convenient
Eas handling in a con
enient lens pack with
ith
easy-to-grip tab and tear-away label. And it’s
patient-preferred for ease of insertion and
removal.
Eye care professionals reported 99% of patients
were an easy fit.6 No additional chair time is
necessary – posterior geometry is identical to
SofLens one day lenses.
BRINGING PRESBYOPES TO YOUR PRACTICE
THE RESULTS ARE IN
The right opportunity for you.
A 2,314 patient study showed the Bausch & Lomb
Lo-Torque design delivers on its promise of high
performance.
7
Key facts you should know about the presbyopic market :
million baby
boomers are
becoming
presbyopic
presbyopes don’t
know that
Multi-Focal lenses
are an option
of contact
lens
wearers
of spectacle
wearers are
interested
in trying
Multi-Focals
of eye care professionals
said fitting more presbyopes
is the best way to grow
their lens business
Bausch & Lomb recently launched a new Multi-Focal commercial on your patients’
favorite cable channels – which means they’ll be turning to you for the exceptional
vision of our #1 selling Multi-Focal lens design.
85% of practitioners facilitating the study reported
they were glad they refit these patients into
Bausch & Lomb Toric lenses.
In the study, competitive toric lens wearers were
refit with Bausch & Lomb PureVision Toric contact
lenses. PureVision Toric lenses showed good to
excellent results on:
The right tools to meet this demand.
We’ve made it easy for you to leverage the
same information and resources that have
helped many eye care practitioners become
very successful specialty lens fitters. Go to
www.presbyopesinyourpractice.com today
for tools and information you need to
become an expert Multi-Focal contact lens
fitter and grow your business.
• Lens fitting assistant
• Fitting tips
• Practitioner videos
Patients rely on you to deliver the best vision
possible. And of the 2,314 patients in the refit
study, 94% reported good to excellent vision with
the Bausch & Lomb Toric lens.11
• Practice management tools
• Case studies and articles from
other eye care professionals
SPRING ALLERGY SEASON IS COMING – ARE YOU READY?
ALREX® Ophthalmic Suspension is
indicated for the temporary relief of the
signs and symptoms of seasonal allergic
conjunctivitis. Please see full
prescribing information here.
While combination antihistamine/mast
cell stabilizer products primarily address
early phase mediators, ALREX®
(loteprednol etabonate ophthalmic
suspension 0.2%) provides
comprehensive coverage of the complete
inflammatory cascade.8 9
Despite the fact that ALREX provides
corticosteroid strength to fight the entire
allergic cascade, ALREX has a favorable
long-term safety profile.10 A retrospective
multicenter study analyzed 159 patients
using ALREX continuously without adverse
effects for more than one year. Of these
patients, 84 were treated for at least two
years while 22 were treated for at least
three years.
In this study, there were no significant
changes (>5 mm Hg) in IOP from
baseline, and no patient developed a new
posterior subcapsular cataract or
significant worsening of a previously
existing cataract.
As with other ophthalmic corticosteroids,
ALREX is contraindicated in most viral
diseases of the cornea and conjunctiva,
and in mycobacterial and fungal diseases
of the eye. Prolonged use of the
corticosteroids may result in secondary
glaucoma, cataract formation, and
secondary ocular infections following
suppression of the host immune response
and/or perforation of the globe. The most
common adverse events in patients
treated with ALREX were abnormal vision,
blurring, burning, chemosis, discharge,
dry eyes, epiphora, foreign body
sensation, itching, and photophobia.
Non-ocular adverse reactions include
headache, rhinitis, and pharyngitis.
>continued on next page
WAL-MART DOCTORS GIVE
PUREVISION CONTACT
LENSES HIGH RATINGS
The overwhelming majority of your peers found
Bausch & Lomb PureVision® spherical lenses in 8.3
base curve deliver outstanding performance.
In an 1,800 patient study, eye care
professionals ranked Bausch & Lomb PureVision
spherical lenses very high.
&%%
-%
-,
+%
.%
--
K^h^dc
FjVa^in
DkZgVaa
K^h^dc
,(
-(
)%
'%
%
:VhZd[;^i
DkZgVaa
8db[dgiÄ
>c^i^Va;^i
DkZgVaa
Dc":nZ
EZg[dgbVcXZ
• The average rating for overall vision
was 8.8
• The average rating for overall comfort
was 8.1.12
>Spring Allergy continued from previous page
Treat it right from the start with ALREX – the treatment that provides coverage
without compromise.
SEND QUESTIONS OR
COMMENTS TO:
Eyemattersfeedback@bausch.com
FOOTNOTES
1
Gallup 2006 survey of prospective lens wearers.
2
Clinical evaluation conducted at 117 sites in 8 different countries. 152 spherical contact lens wearers were refit in the Bausch &
Lomb PureVision Toric lens. Data on file Bausch & Lomb.
3
A quantitative survey conducted among 95 optometrists. On average, respondents have been in practice for 14 years, and fit 21 toric
patients per week. For a variety of factors, doctors were asked to indicate a preference for PureVision Toric, Acuvue Advance for
Astigmatism, or no preference. Data on file Bausch & Lomb.
4
A comparative study of PureVision Toric and SofLens66 Toric lenses.
Data on file Bausch & Lomb.
5
Forty subjects participated in an evaluation of spherical aberration with SofLens daily disposable contact lenses. Subjects were
dilated to achieve a minimum of 6 mm pupil diameter. Baseline spherical aberration was measured using a Zywave™ aberrometer.
SofLens daily disposable contact lenses (-1.00D and -5.00D) were inserted, and the measurement of spherical aberration was
repeated. Wavefront aberration maps and simulated retinal images were generated using Vision Optics Laboratory software. The
letter represents a 20/80 letter size viewed through a 6 mm pupil and an eye with no other aberration except for spherical
aberration.
6
Bausch & Lomb Clinical Research Report (data on file). A total of 84 adapted contact lens patients participated in a 4-week,
cross-over clinical investigation of SofLens daily disposable and SofLens one day contact lenses. Patients were instructed to wear the
lenses on a daily wear, daily disposable basis. At the completion of the study, patients completed a product attribute rating and a
forced-choice preference questionnaire.
7
2005 Gallup study of consumer contact lens market. Data on file Bausch & Lomb.
8
Slonim CB. The ocular response. Rev Ophthalmol. 2000;7:101-112.
9
Slonim CB, Boone R. The ocular response: a pharmacotherapeutic review. Formulary. 2004;39:213-222.
10
Ilyas H, Slonim CB, Braswell GR, et. al. Long term study of loteprednol etabonate 0.2% in the treatment of seasonal and perennial
allergic conjunctivitis. Eye Contact Lens. 2004; 30:10-13.
11
Zenith Study fielded in June 2007 among 71 eye care practitioners and 2,314 patients. ACUVUE Advance for Astigmatism, Proclear
Toric, Frequency 55 Toric and Biomedics Toric lens wearers were fit in PureVision Toric contact lenses for 2 weeks. Data on file
Bausch & Lomb.
12
Data on file Bausch & Lomb.
© 2008 Bausch & Lomb Incorporated. Bausch & Lomb, Lo-Torque, Alrex, SofLens, SofLens66, PureVision, Perfecting Vision. Enhancing Life. are
registered trademarks of Bausch & Lomb. All other product/brand names are trademarks of their respective owners.